Related Experiment Video

Updated: May 13, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor

T M Becker1, S C Boyd1, B Mijatov1

  • 1Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia.

Oncogene
|March 5, 2013
PubMed

Insights

Mutant BRAF drives melanoma growth and resistance to targeted therapies. This study reveals that BRAF signaling activates STAT3, which increases Mcl-1 production, promoting melanoma cell survival and chemoresistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Melanoma is often driven by mutations in BRAF, a key signaling protein.
  • Targeted BRAF inhibitors show initial efficacy but acquired resistance limits long-term patient benefit.
  • Understanding downstream targets of BRAF is crucial for developing new melanoma therapies.

Purpose of the Study:

  • To investigate the role of BRAF signaling in regulating the expression of the anti-apoptotic protein Mcl-1 in melanoma.
  • To determine if STAT3 activation is involved in BRAF-mediated Mcl-1 induction and melanoma cell survival.

Main Methods:

  • Analysis of Mcl-1 expression and phosphorylation in melanoma cells.
  • Investigating the effect of BRAF(V600E) on STAT3 phosphorylation (serine-727 and tyrosine-705).
  • Assessing the impact of STAT3 inhibition on Mcl-1 promoter activity and melanoma cell viability.

Main Results:

  • BRAF(V600E) signaling induces both the transcription and stabilizing phosphorylation of Mcl-1.
  • BRAF(V600E) promotes STAT3 activation at serine-727 and tyrosine-705.
  • STAT3 activity is required for BRAF-mediated Mcl-1 induction and melanoma cell survival.

Conclusions:

  • STAT3 plays a critical role in BRAF(V600E)-driven melanoma.
  • STAT3 activation contributes to Mcl-1 upregulation, promoting melanoma cell survival and chemoresistance.
  • Targeting STAT3 may represent a viable therapeutic strategy for BRAF-mutant melanoma.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...